Showing 1 posts of 1 posts found.
High Force Research has announced that it has appointed Nathalie Huther as its first chief commercial officer (CCO) following the …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement